• ≡ İ
  • ≡ CHCAM
  • Ѷ
  • Shuzheng Health
  • Homepage
  • »
  • Enterprise Statue
  • Back
  • WHAT OUR CLIENTS SAY
  • "Shuzheng surpassed my expectations and took a genuine " --Tongrentang
  • "We sincerely apprec-iate the professional and courteous manner " --Jameison
  • Enterprise Statue
  • China witnessed each phases of the development of health care industry, which experienced starting up, emerging, flourishing, inflating and standardized. The first phases, which from 1949 to 1979, was based on the market of tonic and invigorant. And Chinese traditional medicine took a great share among them. From...
  • China witnessed each phases of the development of health care industry, which experienced starting up, emerging, flourishing, inflating and standardized.

    The first phases, which from 1949 to 1979, was based on the market of tonic and invigorant. And Chinese traditional medicine took a great share among them. From 1980-1985, it entered into the second phase for healthcare industry. Oral liqid, vitamin and royal jelly took up major market share. From 1986-1990, the healthcare industry went through a great development phase. At that time, new brands and products emerged into market, and the salesroom risen up sharply. From 1991-1995, the market experienced a time of disorder development. For one thing, the amount of health products increased quickly and the technical enhanced greatly, for the other, some illegal enterprises came into the market, and its hard for people to identify whether is real products or not. Up to 1996, Chinas healthcare market went into standard. Several regulations and rules have been published by related supervision institutions. More of the overseas enterprises seek the opportunity of development in the mainland of China. 

    With the enhancement of the awareness of health, Chinas health products market got a unprecedented development in the latest four to five years. According to statistics, the market capability has reached RMB 50 billion (about US$ 625 Million), and will reach RMB 100 billion (about 12.5 Billion) by some forecasters.

  • Ѷ
  • Shuzheng Health
  • HomePrivacy PolicyTerm of UsesLinks© 2017 Shuzheng Health (Beijing) Commercial Consultation Co., Ltd.